Genetic evaluation in primary dystonia

Handbook of Dystonia

Volumn , Issue , 2006, Pages 21-44

  Klein, Christine ^a   Ozelius, Laurie J ^b   Breakefield, Xandra O ^c,d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34447333672     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (184)

1. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol 1998; 78: 1-13.
2. Quinn NP. Parkinsonism and dystonia, pseudo-parkinsonism and pseudodystonia. Adv Neurol 1993; 60: 540-543.
3. Bressman SB. Dystonia genotypes, phenotypes, and classification. Adv Neurol 2004; 94: 101-107.
4. Wenning GK, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol 2005; 4: 815-820.
5. Klein C, Breakefield XO, Ozelius LJ. Genetics of primary dystonia. Semin Neurol 1999; 19: 271-280.
6. Klein C, Ozelius LJ. Movement disorders: classifications. J Inherit Metab Dis 2002; 28: 425-439.
7. Klein C. Movement disorders: classifications. J Inherit Metab Dis 2005; 28: 425-439.
8. Kabakci K, Hedrich K, Leung J-C, et al. Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology 2004; 62: 395-400.
9. Kock N, Kasten M, Schule B, et al. Clinical and genetic features of myoclonus-dystonia in 3 cases: a video presentation. Mov Disord 2004; 19: 231-234.
10. Hagenah JM, Zuhlke C, Hellenbroich Y, et al. Focal dystonia as a presenting sign of spinocerebellar ataxia 17. Mov Disord 2004; 19: 217-220.
11. Leung J, Klein C, Friedman J, et al. Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001; 3: 133-143.
12. Leube B, Rudnicki D, Ratzlaff T, et al. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet 1996; 5: 1673-1677.
13. Gasser T, Windgassen K, Bereznai B, et al. Phenotypic expression of the DYT1 mutant: a family with writer’s cramp of juvenile onset. Ann Neurol 1998; 44: 126-128.
14. Valente EM, Bentivoglio AR, Cassetta E, et al. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Ann Neurol 2001; 49: 362-366.
15. Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000; 54: 1746-1752.
16. Hagenah J, Saunders-Pullman R, Hedrich K, et al. High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology 2005; 64: 908-911.
17. De Berardinis RJ, Conforto D, Russell K, et al. Myoclonus in a patient with a deletion of the epsilon-sarcoglycan locus on chromosome 7q21. Am J Med Genet 2003; 121A: 31-36.
18. Asmus F, Salih F, Hjermind LE, et al. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol 2005; 58: 792-797.
19. Klein C, Friedman J, Bressman S, et al. Genetic testing for early-onset torsion dystonia (DYT1): Introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test 1999; 3: 323-328.
20. Ghilardi MR, Carbon M, Silvestri G, et al. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol 2003; 54: 102-109.
21. Carbon M, Kingsley PB, Su S, et al. Microstructural white matter changes in carriers of the DYT1 gene mutation. Ann Neurol 2004; 56: 283-286.
22. Asanuma K, Ma Y, Okulski J, et al. Decreased striatal D2 receptor binding in nonmanifesting carriers of the DYT1 dystonia mutation. Neurology 2005; 64: 347-349.
23. Risch N, de Leon D, Ozelius LJ, et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 1995; 9: 152-159.
24. Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988; 3: 188-194.
25. Bressman SB, de Leon MS, Kramer PL, et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol 1994; 36: 771-777.
26. Ozelius LJ, Hewett J, Page C, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17: 40-48.
27. Risch NJ, Bressman SB, de Leon D, et al. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am J Hum Genet 1990; 46: 533-538.
28. Kamm C, Naumann M, Mueller J, et al. The DYT1 GAG deletion is infrequent in sporadic and familial writer’ s cramp. Mov Disord 2000; 15: 1238-1241.
29. Eidelberg D, Moeller JR, Antonini A, et al. Functional brain networks in DYT1 dystonia. Ann Neurol 1998; 44: 299-300.
30. Heiman GA, Ottman R, Saunders-Pullman RJ, et al. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology 2004; 63: 631-637.
31. Edwards M, Huang Y-Z, Wood NW, et al. Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain 2003; 126: 2074-2080.
32. Saunders-Pullman R, Shriberg J, Shanker V, et al. Penetrance and expression of dystonia genes. Adv Neurol 2004; 94: 121-125.
33. Klein C, Brin MF, de Leon D, et al. De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia. Hum Mol Genet 1998; 7: 1133-1136.
34. Klein C, Liu L, Doheny D, et al. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann Neurol 2002; 52: 675-679.
35. Clarimon J, Asgeirsson H, Singleton A, et al. TorsinA haplotype predisposes to idiopathic dystonia. Ann Neurol 2005; 57: 765-767.
36. Neuwald AF, Aravind L, Spouge JL, et al. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 1999; 9: 27-43.
37. Lupas A, Flanagan JM, Tamura T, et al. Self-compartmentalization proteases. Trends Biochem Sci 1997; 22: 399-404.
38. Hanson PI, Whiteheart SW. AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol 2005; 6: 519-529.
39. Vale RD. AAA proteins: Lords of the ring. J Cell Biol 2000; 150: F13-F19.
40. Augood SJ, Keller-McGandy CE, Siriani A, et al. Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Res 2003; 986: 12-21.
41. Rostasy K, Augood SJ, Hewett JW, et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol Dis 2003; 12: 11-24.
42. Shashidharan P, Kramer BC, Walker R, et al. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res 2000; 853: 197-206.
43. Xiao J, Gong S, Zhao Y, et al. Developmental expression of rat torsinA transcript and protein. Brain Res Dev Brain Res 2004; 152: 47-60.
44. Siegert S, Bahn E, Kramer M, et al. TorsinA expression is detectable in human infants as young as four weeks old. Brain Res Dev Brain Res 2005; 157: 19-26.
45. Vasudevan A, Breakefield XO, Bhide PG. TorsinA and torsinB expression in the developing mouse brain. Mol Brain Res: 2006; 1073-1074: 139-145.
46. Goodchild RE, Kim CE, Dauer WT. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005; 48: 923-932.
47. Dang M, Yokoi F, Li Y. Motor deficits and hyperactivity in DYT1 knockdown mice. Mol Brain Res 2005; 196: 452-463.
48. Hewett J, Gonzalez-Agosti C, Slater D, et al. Mutant torsin A, responsible for early onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet 2000; 22: 1403-1413.
49. Kustedjo K, Bracey MH, Cravatt BF. TorsinA and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem 2000; 275: 27933-27939.
50. Naismith TV, Heuser JE, Breakefield XO, et al. TorsinA in the nuclear envelope. Proc Natl Acad Sci USA 2004; 101: 7612-7617.
51. Goodchild RE, Dauer WT. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. Cell Biol 2005; 168: 855-862.
52. McNaught KS, Kapustin A, Jackson T, et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann Neurol 2004; 56: 540-547.
53. Hedreen JC, Zweig RM, DeLong MR, et al. Primary dystonias: a review of the pathology and suggestions for new directions of study. Adv Neurol 1988; 50: 123-132.
54. Walker RH, Brin MF, Sandu D, et al. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology 2002; 58: 120-124.
55. Hewett J, Zeng J, Bragg DC, Breakefield XO. Dystonia-causing mutant form of torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol Dis 2006; 22: 98-111.
56. Torres GE, Sweeney AL, Beaulieu JM, et al. Effect of torsinA on membrane proteins reveals a loss of function and a dominant negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci USA 2004; 101: 15650-15655.
57. McLean PJ, Kawamata H, Shariff S, et al. TorsinAand heat shock proteins act asmolecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem 2002; 83: 846-854.
58. Cao S, Gelwix CC, Caldwell KA, et al. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J Neurosci 2005; 25: 3801-3812.
59. Wong VCN, Lam C-W, Fung WC. Stiff child syndrome with mutation of DYT1 gene. Neurology 2005; 65: 1465-1466.
60. Opal P, Tintner R, Jankovic J, et al. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord 2002; 17: 339-345.
61. Gatto EM, Pardal MM, Micheli FE. Unusual phenotypic expression of the DYT1 mutation. Parkinsonism Relat Disord 2003; 9: 277-279.
62. Almasy L, Bressman SB, de Leon D, et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol 1997; 42: 670-673.
63. Toda H, Hamani C, Lozano A. Deep brain stimulation in the treatment of dyskinesia and dystonia. Neurosurg Focus 2004; 17: E2 Rev.
64. Coubes P, Cif L, El Fertit H, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 2004; 101: 189-194.
65. Segawa M, Hosaka A, Miyagawa F, et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215-233.
66. Blau N, Bonafe L, Thony B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 2001; 74: 172-185.
67. Grimes DA, Barclay CL, Duff J, et al. Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 2002; 72: 801-804.
68. Bandmann O, Valente EM, Holmans P, et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44: 649-656.
69. Kong CK, Ko CH, Tong SF, et al. Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness. Neurology 2001; 57: 1121-1124.
70. Hahn H, Trant MR, Brownstein MJ, et al. Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene. Arch Neurol 2001; 58: 749-755.
71. Van Hove JLK, Steyaert J, Matthijs G, et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry 2006; 77: 18-23.
72. Nar H, Huber R, Auerbach G, et al. Active site topology and reaction mechanism of GTP cyclohydrolase I. Proc Natl Acad Sci USA 1995; 92: 12120-12125.
73. Nygaard TG, Wooten GF. Dopa-responsive dystonia: some pieces of the puzzle are still missing. Neurology 1998; 50: 853-855.
74. Furukawa Y, Guttman M, Sparagana SP, et al. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol 2000; 47: 517-520.
75. Klein C, Hedrich K, Kabakci K, et al. Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia. Neurology 2002; 59: 1783-1786.
76. Grotzsch H, Pizzolato GP, Ghika J, et al. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002; 58: 1839-1842.
77. Friedman J, Standaert DG. Neurogenetics of dystonia and paroxysmal dyskinesias. In: Lynch DR, ed. Neurogenetics: Scientific and Clinical Advances. Marcel Dekker, New York 2005: 403-426.
78. Steinberger D, Blau N, Goriuonov D, et al. Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics 2004; 5: 187-190.
79. Hirano M, Tamaru Y, Ito H, et al. Mutant GTPcyclohydrolaseI mRNA levels contribute to dopa-responsive dystonia onset. Ann Neurol 1996; 40: 796-798.
80. Hirano M, Imaiso Y, Ueno S. Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Biochem Biophys Res Commun 1997; 234: 316-319.
81. Saunders-Pullman R, Blau N, Hyland K, et al. Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metab 2004; 83: 207-212.
82. www.bh4.org/biomdb.summary.html.
83. Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord 1996; 11: 119-124.
84. Klein C, Gurvich N, Sena-Esteves M, et al. Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann Neurol 2000; 47: 369-373.
85. Vidailhet M, Tassin J, Durif F, et al. A major locus for several phenotypes of myoclonusdystonia on chromosome 7q. Neurology 2001; 56: 1213-1216.
86. Asmus F, Zimprich A, Tezenas Du Montcel S, et al. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 2002; 52: 489-492.
87. Klein C. Myoclonus and myoclonus-dystonias. In: Pulst S, ed. Genetics of Movement Disorders. San Diego: Academic Press, 2003: 449-469.
88. Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 2005; 64: 737-739.
89. Mahooudji M, Pikielny RT. Hereditary essential myoclonus. Brain 1967; 90: 669-674.
90. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilonsarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001; 29: 66-69.
91. Doheny DO, Brin MF, Morrison CE, et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002; 59: 1187-1196.
92. Muller B, Hedrich K, Kock N, et al. Evidence that paternal expression of the epsilonsarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002; 71: 1303-1311.
93. Foncke EM, Klein C, Koelman JH, et al. Hereditary myoclonus-dystonia associated with epilepsy. Neurology 2003; 60: 1988-1990.
94. Han F, Lang AE, Racacho L, et al. Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families. Neurology 2003; 61: 244-246.
95. Hjermind LE, Werdelin LM, Eiberg H, et al. A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome. Neurology 2003; 60: 1536-1539.
96. Marechal L, Raux G, Dumanchin C, et al. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet 2003; 119B: 114-117.
97. Hedrich K, Meyer EM, Schule B, et al. Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology 2004; 62: 1229-1231.
98. Schule B, Kock N, Svetel M, et al. Genetic heterogeneity in ten families with myoclonusdystonia. J Neurol Neurosurg Psychiatry 2004; 75: 1181-1185.
99. Grimes DA, Han F, Lang AE, et al. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002; 59: 1182-1186.
100. Quinn NP, Rothwell JC, Thompson PD, et al. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol 1988; 50: 391-401.
101. Lang AE. Essential myoclonus and myoclonic dystonia. Mov Disord 1997; 12: 127.
102. Saunders-Pullman R, Ozelius L, Bressman SB. Inherited myoclonus-dystonia. Adv Neurol 2002; 89: 185-191.
103. Kyllerman M, Forsgren L, Sanner G, et al. Alcohol-responsive myoclonic dystonia in a large family: Dominant inheritance and phenotypic variation. Mov Disord 1990; 5: 270-279.
104. Klein C, Schilling K, Saunders-Pullman RJ, et al. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 2000; 67: 1314-1319.
105. O’Riordan S, Ozelius LJ, de Carvalho Aguiar P, et al. Inherited myoclonus-dystonia and epilepsy: further evidence of an association? Mov Disord 2004; 19: 1456-1459.
106. Klein C, Brin MF, Kramer P, et al. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci USA 1999; 27: 5173-5176.
107. Nygaard TG, Raymond D, Chen C, et al. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol 1999; 46: 794-798.
108. Asmus F, Zimprich A, Naumann M, et al. Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol 2001; 49: 121-124.
109. Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002; 58: 242-245.
110. Scheidtmann K, Muller F, Hartmann E, et al. Familial myoclonus-dystonia syndrome associated with panic attacks. Nervenarzt 2000; 71: 839-842.
111. Piras G, El Kharroubi A, Kozlov S, et al. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines. Mol Cell Biol 2000; 20: 3308-3315.
112. Grabowski M, Zimprich A, Lorenz-Depiereux B, et al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003; 11: 138-144.
113. McNally EM, Ly CT, Kunkel LM. Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett 1998; 422: 27-32.
114. Yokoi F, Dang MT, Mitsui S, et al. Exclusive paternal expression and novel alternatively spliced variants of epsilon-sarcoglycan mRNA in mouse brain. FEBS Lett 2005; 579: 4822-4828.
115. Nishiyama A, Endo T, Takeda S, et al. Identification and characterization of epsilonsarcoglycans in the central nervous system. Brain Res Mol Brain Res 2004; 125: 1-12.
116. Hack AA, Groh ME, McNally EM. Sarcoglycans in muscular dystrophy. Microsc Res Tech 2000; 48: 167-180.
117. Liu LA, Engvall E. Sarcoglycan isoforms in skeletal muscle. J Biol Chem 1999; 274: 38171-38176.
118. Ettinger AJ, Feng G, Sanes JR. Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 1997; 272: 32534-32538.
119. Xiao J, LeDoux MS. Cloning, developmental regulation and neural localization of rat epsilon-sarcoglycan. Brain Res Mol Brain Res 2003; 119: 132-143.
120. Chan P, Gonzalez-Maeso J, Ruf F, et al. Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J Comp Neurol 2005; 482: 50-73.
121. Tezenas du Montcel S, Clot F, Vidailhet M, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet 2005; 43: 394-400.
122. Valente EM, Misbahuddin A, Brancati F, et al. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 2003; 18: 1047-1051.
123. Grundmann K, Laubis-Herrmann U, Dressler D, et al. Lack of mutations in the epsilonsarcoglycan gene in patients with different subtypes of primary dystonias. Mov Disord 2004; 19: 1294-1297.
124. Dobyns WB, Ozelius LJ, Kramer PL, et al. Rapid-onset dystonia-parkinsonism. Neurology 1993; 43: 2596-2602.
125. Brashear A, Farlow MR, Butler IJ, et al. Variable phenotype of rapid-onset dystonia- parkinsonism. Mov Disord 1996; 2: 151-156.
126. Brashear A, de Leon D, Bressman S, et al. Rapid onset dystonia-parkinsonism: a report of a second family. Neurol 1997; 48: 1066-1069.
127. Webb DW, Broderick A, Brashear A, et al. Rapid onset dystonia-parkinsonism in a 14-year-old girl. Europ J Paediatr Neurol 1999; 3: 171-173.
128. Pittock SJ, Joyce CO, Keane V. Rapid onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology 2000; 55: 991-995.
129. Brashear A, Butler IJ, Hyland K, et al. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol 1998; 43: 521-526.
130. Kramer PL, Mineta M, Klein C, et al. Rapid-onset dystonia parkinsonism: Linkage to chromosome 19q13. Ann Neurol 1999; 46: 176-182.
131. Zaremba J, Mierzewska H, Lysiak Z, et al. Rapid-onset dystonia-parkinsonism: a fourth family consistent with linkage to chromosome 19q13. Mov Disord 2004; 19: 1506-1510.
132. +-ATPase 3 gene ATP1A3 are associated with rapid onset dystonia parkinsonism. Neuron 2004; 43: 169-175.
133. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33: 192-196.
134. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003; 54: 360-366.
135. Mount L, Reback S. Familial paroxysmal choreoathetosis preliminary report on an mitheric undescribed clinical syndrome. Arch Neurol Psychiatry 1940; 44: 841-847.
136. Fahn S. Concept and classification of dystonia. Adv Neurol 1988; 50: 1-8.
137. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38: 571-579.
138. Fouad GT, Servidei S, Durcan S, et al. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 1996; 59: 135-139.
139. Fink JK, Rainier S, Wilkowski J, et al. Paroxysmal dystonic choreoathetosis: Tight linkage to chromosome 2q. Am J Hum Genet 1996; 59: 140-145.
140. Raskind WH, Bolin T, Wolff J, et al. Further localization of a gene for paroxysmal dystonic choreoathetosis to a 5-cM region on chromosome 2q34. Hum Genet 1998; 102: 93-97.
141. Munchau A, Valente EM, Davis MB, et al. A Yorkshire family with adult-onset craniocervical primary torsion dystonia. Mov Disord 2000; 15: 954-959.
142. Lee HY, Xu Y, Huang Y, et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004; 13: 3161-3170.
143. Rainier S, Thomas D, Tokarz D, et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol 2004; 61: 1025-1029.
144. Chen DH, Matsushita M, Rainier S, et al. Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds. Arch Neurol 2005; 62: 597-600.
145. Djarmali A, Svetel M, Momcilovic D, et al. Significance of recurrent mutations in the myofibrillogenesis regulator 1 gene. Arch Neurol 2005; 62: 1641.
146. Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med 1993; 14: 287-371.
147. Lee LV, Pascasio FM, Fuentes FD, et al. Torsion dystonia in Panay, Philippines. Adv Neurol 1976; 14: 137-151.
148. Evidente VG, Nolte D, Niemann S, et al. Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (“lubag”) in women. Arch Neurol 2004; 61: 1956-1959.
149. Factor SA, Barron KD. Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism. Mov Disord 1997; 12: 783-789.
150. Gibb WR, Kilford L, Marsden CD. Severe generalised dystonia associated with a mosaic pattern of striatal gliosis. Mov Disord 1992; 7: 217-223.
151. Waters CH, Faust PL, Powers J, et al. Neuropathology of lubag (X-linked dystonia parkinsonism). Mov Disord 1993; 8: 387-390.
152. Lee LV, Munoz EL, Tan KT, et al. Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Mol Pathol 2001; 54: 362-368.
153. Goto S, Lee LV, Munoz EL, et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005; 58: 7-17.
154. Kupke KG, Lee LV, Mueller U. Assigment of the X-linked torsion dystonia gene to Xq21 by linkage analysis. Neurology 1990; 40: 1438-1442.
155. Wilhelmsen KD, Weeks DE, Nygaard TG, et al. Genetic mapping of “lubag” (X-linked Dystonia-Parkinsonism) is a Filipino kindred to the pericentromeric region of the X chromosomes. Ann Neurol 1991; 29: 124-131.
156. Nolte D, Niemann S, Muller U. Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism. Proc Natl Acad Sci USA 2003; 100: 10347-10352.
157. Plummer C, Bradfield J, Singleton AB, et al. First case report of X linked dystonia parkinsonism (XDP) or ‘lubag’ in Australia. J Clin Neurosci 2005; 12: 946-947.
158. Gimenez-Roldan S, Delgado G, Marin M, et al. Hereditary torsion dystonia in gypsies. Adv Neurol 1988; 50: 73-81.
159. Khan NL, Wood NW, Bhatia KP. Autosomal recessive, DYT2-like primary torsion dystonia: a new family. Neurology 2003; 61: 1801-1803.
160. Moretti P, Hedera P, Wald J, et al. Autosomal recessive primary generalized dystonia in two siblings from a consanguineous family. Mov Disord 2005; 20: 245-247.
161. Parker N. Hereditary whispering dysphonia. J Neurol Neurosurg Psychiatry 1985; 48: 218-224.
162. Ahmad F, Davis MB, Waddy HM, et al. Evidence for locus heterogeneity in autosomal dominant torsion dystonia. Genomics 1993; 15: 9-12.
163. ESDE Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000; 247: 787-792.
164. Defazio G, Livrea P, Guanti G, et al. Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol 1993; 33: 345-350.
165. Waddy HM, Fletcher NA, Harding AE, et al. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29: 320-324.
166. Leube B, Kessler KR, Goecke T, et al. Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family. Mov Disord 1997; 12: 1000-1006.
167. Uitti RJ, Maraganore DM. Adult onset familial cervical dystonia: report of a family including monozygotic twins. Mov Disord 1993; 8: 489-494.
168. Bressman SB, Warner TT, Almasy L, et al. Exclusion of the DYT1 locus in familial torticollis. Ann Neurol 1996; 40: 681-684.
169. Schmidt A, Jabusch HC, Altemmuller E, et al. Dominantly transmitted focal dystonia in families of patients with musician’s cramp. Neurology. 2006; 67: 691-693.
170. Klein C, Page CE, Le Witt P, et al. Genetic analysis of three patients with an 18psyndrome and dystonia. Neurology 1999; 52: 649-651.
171. Tezzon F, Zanoni T, Passarin MG, et al. Dystonia in a patient with deletion of 18p. Ital J Neurol Sci 1998; 19: 90-93.
172. Klein C, Pramstaller PO, Claudio MD, et al. Clinical and genetic evaluation of a family with a mixed dystonia phenotype from South Tyrol. Ann Neurol 1998; 44: 394-398.
173. Jarman PR, del Grosso N, Valente EM, et al. Primary torsion dystonia: the search for genes is not over. J Neurol Neurosurg Psychiatry 1999; 67: 395-397.
174. Brancati F, Defazio G, Caputo V, et al. Novel Italian family supports clinical and genetic heterogeneity of primary adult-onset torsion dystonia. Mov Disord 2002; 17: 392-397.
175. Auburger G, Ratzlaff T, Lunkes A, et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996; 31: 90-94.
176. Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 1967; 17: 680-690.
177. Walker ES. Familial paroxysmal dystonic choreoathetosis: a neurologic disorder simulating psychiatric illness. Johns Hopkins Med J 1981; 148: 108-113.
178. Bruno MK, Hallett M, Gwinn-Hardy K, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 2004; 63: 2280-2287.
179. Tomita H, Nagamitsu S, Wakui K, et al. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet 1999; 65: 1688-1697.
180. Swoboda KJ, Soong BW, McKenna C, et al. Paroxysmal kinesigenic dyskinesia and infantile convulsions. Clinical and linkage studies. Neurology 2001; 57: S42-S48.
181. Caraballo R, Pavek S, Lemainque A, et al. Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001; 68: 788-794.
182. Bentivoglio AR, Del Grosso N, Albanese A, et al. Non-DYT1 dystonia in a large Italian family. J Neurol Neurosurg Psychiatry 1997; 62: 357-360.
183. Defazio G, Brancati F, Valente EM, et al. Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene. Mov Disord 2003; 18: 207-212.
184. Fabbrini G, Brancati F, Vacca L, et al. A novel family with an unusual early-onset generalized dystonia. Mov Disord 2005; 20: 81-86.